AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.

Oncotarget · 2014 · PMC4294386 · PMID 25473890

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

only marginally significantp=0.055so close (0.05 < p ≤ 0.1)

However, the unfavorable genotypes became only marginally significant (p=0.055).

also in 5,085 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.